200 Mg Sorafenib Tablets IP

Name: 200 Mg Sorafenib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 7000 INR
Availability: InStock

Price 7000 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

200 Mg Sorafenib Tablets IP Specification

Dosage Form
Film-coated Tablet

Salt Composition
Sorafenib Tosylate 200 mg

Indication
Hepatocellular carcinoma, Advanced renal cell carcinoma, Thyroid carcinoma

Enzyme Types
Tyrosine kinase inhibitor

Feature
High specificity for targeted cancer therapy

Ingredients
Active: Sorafenib Tosylate; Excipients: Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Colloidal silicon dioxide

Application
Oral administration as anti-cancer therapy

Physical Color/Texture
Light yellow, round, film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits various kinases involved in tumor cell proliferation

Storage Instructions
Store below 30°C, protect from moisture

Shelf Life
24 months from date of manufacture

Trade Name
Sorafenib Tablets IP

Pack Size
30 tablets per box

Product Code
SORF200

Strength
200 mg

Prescription Status
Prescription only

Packaging Type
Blister pack

Expiry Details
Printed on pack

About 200 Mg Sorafenib Tablets IP

Advance Purchase of 200 Mg Sorafenib Tablets IP (SORF200) is Highly Recommended for oncologists seeking a Rare, Noble solution for advanced hepatocellular carcinoma, renal cell carcinoma, and thyroid carcinoma. These Excellent, prescription-only, light yellow, round, film-coated tablets deliver Sorafenib Tosylate 200 mg per dose, targeting multiple kinases to inhibit tumor proliferation. Manufactured with Enlightened care by a leading distributor and exporter in India, each blister pack contains 30 odorless tablets. Designed for high specificity and efficacy, this anti-cancer therapy is for oral use. Expiry and storage details are clearly printed on the packaging for transparency.

Targeted Oral Cancer Therapy for Advanced Cases

200 Mg Sorafenib Tablets IP offers a Noble and Excellent application for treating various cancers through oral administration. Its main site of action is the inhibition of tumor-causing kinases in liver, kidney, and thyroid cells. This targeted approach ensures high specificity for cancer therapy, with each light yellow, film-coated tablet designed for patient comfort. The film-coating and tablet size support ease of swallowing during long-term treatment. Application is strictly through oral ingestion, following prescription guidance.

Sample Policy, Delivery Assurance, and Supply Capacity

Samples for 200 Mg Sorafenib Tablets IP may be supplied on request, subject to applicable charges and distributor policies. Goods transport is handled efficiently to assure timely delivery throughout India and international markets. Supply ability remains Excellent, with robust inventory levels maintained to meet urgent and routine demand. Buyers can expect reliable and rapid dispatch after order confirmation, with ample shelf life and secure blister packaging protecting the goods during transit.

FAQ's of 200 Mg Sorafenib Tablets IP:

Q: How should 200 Mg Sorafenib Tablets IP be administered?

A: The tablets are meant for oral administration, taken exactly as prescribed by your healthcare provider. Do not crush or split the film-coated tablets.

Q: What types of cancer is Sorafenib Tablets IP indicated for?

A: Sorafenib Tablets IP is used for the treatment of advanced hepatocellular carcinoma, advanced renal cell carcinoma, and thyroid carcinoma.

Q: When is it advisable to consider advance purchase of this product?

A: Advance Purchase is highly recommended for treatment centers and specialists dealing with rare oncology cases to ensure uninterrupted supply and timely therapy initiation.

Q: Where can I find expiry and storage details for these tablets?

A: Expiry and storage instructions are clearly printed on each pack. Store the product below 30C and protect from moisture for stability and efficacy.

Q: What are the major benefits of using Sorafenib Tablets IP?

A: The major benefit is its high specificity as a tyrosine kinase inhibitor, effectively targeting tumor cell proliferation with a Noble mechanism designed for advanced cancer patients.

Q: What is the process for obtaining sample tablets?

A: Samples may be provided in accordance with distributor policy, and there may be charges involved. Contact your supplier directly for the sample request process.

Tell us about your requirement